Acutus Medical (AFIB) Competitors $0.05 0.00 (-7.59%) As of 02/21/2025 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainSEC FilingsTrends AFIB vs. CTCX, NUWE, CHEK, TNON, SINT, TTOO, HSCS, AMIX, NDRA, and GMVDFShould you be buying Acutus Medical stock or one of its competitors? The main competitors of Acutus Medical include Carmell (CTCX), Nuwellis (NUWE), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), T2 Biosystems (TTOO), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. Acutus Medical vs. Carmell Nuwellis Check-Cap Tenon Medical Sintx Technologies T2 Biosystems Heart Test Laboratories Autonomix Medical ENDRA Life Sciences G Medical Innovations Carmell (NASDAQ:CTCX) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, community ranking, analyst recommendations, dividends, valuation, earnings, media sentiment and risk. Which has more volatility & risk, CTCX or AFIB? Carmell has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. Do insiders and institutionals believe in CTCX or AFIB? 24.2% of Carmell shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 29.0% of Carmell shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is CTCX or AFIB more profitable? Carmell has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Carmell's return on equity of -217.50% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets CarmellN/A -217.50% -50.22% Acutus Medical -272.74%-311.64%-11.57% Does the MarketBeat Community prefer CTCX or AFIB? Acutus Medical received 12 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformCarmellN/AN/AAcutus MedicalOutperform Votes1232.43% Underperform Votes2567.57% Does the media prefer CTCX or AFIB? In the previous week, Carmell's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment Carmell Neutral Acutus Medical Neutral Which has higher earnings & valuation, CTCX or AFIB? Carmell has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCarmellN/AN/A-$15.44MN/AN/AAcutus Medical$7.16M0.22-$81.66MN/AN/A SummaryCarmell beats Acutus Medical on 5 of the 9 factors compared between the two stocks. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition Export to ExcelMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.73M$4.74B$5.84B$9.15BDividend YieldN/A39.90%4.75%3.85%P/E RatioN/A28.5326.1519.13Price / Sales0.2253.64435.3370.72Price / CashN/A51.1038.0134.83Price / Book-1.796.577.644.62Net Income-$81.66M$90.91M$3.19B$245.94M7 Day PerformanceN/A-2.39%-2.11%-2.62%1 Month PerformanceN/A-2.29%-0.49%-2.15%1 Year PerformanceN/A15.21%16.44%12.95% Acutus Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.05-7.6%N/A-75.5%$1.73M$7.16M0.00340CTCXCarmellN/A$0.28-9.2%N/A-92.2%$5.90MN/A0.0014NUWENuwellis2.056 of 5 stars$1.33+4.7%$17.00+1,178.2%-94.0%$5.81M$8.86M-0.0170News CoverageGap DownCHEKCheck-Cap0.4446 of 5 stars$0.90-2.2%N/A-68.1%$5.27MN/A-0.3080Analyst ForecastTNONTenon Medical1.6827 of 5 stars$1.46-2.3%$5.50+278.0%+23.0%$4.57M$2.93M-0.058SINTSintx Technologies0.9952 of 5 stars$3.06-5.6%N/A-82.2%$4.10M$2.63M-0.0640News CoverageGap DownTTOOT2 Biosystems2.2525 of 5 stars$0.19-7.4%$5.00+2,472.0%-96.8%$4.09M$7.68M0.00180Analyst ForecastNews CoverageHigh Trading VolumeHSCSHeart Test Laboratories2.4729 of 5 stars$3.59-5.5%$13.50+276.0%-69.2%$3.52M$20,000.00-0.4510AMIXAutonomix Medical1.8523 of 5 stars$2.72+0.7%$28.00+929.4%-96.2%$3.13MN/A-0.171News CoverageNDRAENDRA Life Sciences2.3514 of 5 stars$4.98-5.3%$700,000.00+14,056,124.9%-100.0%$2.67MN/A-0.0120GMVDFG Medical InnovationsN/AN/AN/A-99.3%$2.60M$4.42M0.0072 Related Companies and Tools Related Companies CTCX Competitors NUWE Competitors CHEK Competitors TNON Competitors SINT Competitors TTOO Competitors HSCS Competitors AMIX Competitors NDRA Competitors GMVDF Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AFIB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
